Contact
Social
Category & trade
Primary
substance-abuse · embed-ft 0.59
Tree path
Medical Health › Diseases and Conditions › Substance Abuse
Group (tier-1)
Tech stack
AI readiness
AI-Readiness score
34 / 100 · partial · see similar
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
Compliance (GEO / GDPR)
TLD
Overview
Title
Home | BRIXADI® (buprenorphine) extended-release injection for subcutaneous use (CIII)
Description
Official HCP site for BRIXADI, the only FDA-approved injectable buprenorphine for opioid use disorder (OUD) that offers weekly and monthly doses. Please see Full Prescribing Information, including Boxed Warning.
Final URL
Language
en (html)
Scanned at
2026-06-19 22:43:16